论文部分内容阅读
本文分析单用舒普深治疗老年人下呼吸道感染的临床有效性及安全性 ,并运用泰能作为对照。共入选 82例 ,其中观察组 (舒普深 ) 4 8例 ,治愈率为 72 .9% (35 / 48) ,有效率为 89.6 % (4 3/ 48) ;对照组 (泰能 ) 34例 ,治愈率为 70 .6 % (2 4/ 34) ,有效率为 88.2 % (30 / 34) ;经统计学处理 ,两组差异无显著性 (P>0 .0 5 )。用药后两组并发霉菌感染的发生率分别为 10 .4% (5 / 48)和 17.6 % (6 / 34) P<0 .0 5 ,两组有明显差异。提示两组有很强的抗细菌感染作用 ,舒普深的耐受性更好
This article analyzes the clinical efficacy and safety of Shufeng Shen alone in the treatment of lower respiratory tract infections in the elderly, and the use of Thai as a control. A total of 82 patients were enrolled in this study. Forty-eight cases were observed in the observation group (Shu Pu-Shen) with a cure rate of 72.9% (35/48) and an effective rate of 89.6% (34/48) , The cure rate was 70.6% (24/34) and the effective rate was 88.2% (30/34). There was no significant difference between the two groups after statistical analysis (P> 0.05). The rates of concurrent mold infection in both groups were 10.4% (5/48) and 17.6% (6/34) P <0.05, respectively, with significant differences between the two groups. Tip two groups have a strong anti-bacterial effect, Shuxu deep tolerance better